SG Americas Securities LLC decreased its position in shares of Steris Plc (NYSE:STE) by 62.3% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,957 shares of the medical equipment provider’s stock after selling 9,846 shares during the quarter. SG Americas Securities LLC’s holdings in Steris Plc were worth $485,000 as of its most recent SEC filing.
A number of other institutional investors have also recently added to or reduced their stakes in STE. BlackRock Inc. raised its holdings in Steris Plc by 16,597.1% during the 1st quarter. BlackRock Inc. now owns 5,272,105 shares of the medical equipment provider’s stock worth $366,200,000 after purchasing an additional 5,240,530 shares during the last quarter. Wellington Management Group LLP raised its holdings in Steris Plc by 77.8% during the 1st quarter. Wellington Management Group LLP now owns 6,529,610 shares of the medical equipment provider’s stock worth $453,547,000 after purchasing an additional 2,856,744 shares during the last quarter. Bessemer Group Inc. raised its holdings in Steris Plc by 944,971.1% during the 2nd quarter. Bessemer Group Inc. now owns 1,342,001 shares of the medical equipment provider’s stock worth $109,373,000 after purchasing an additional 1,341,859 shares during the last quarter. Harbour Capital Advisors LLC bought a new stake in shares of Steris Plc in the 2nd quarter valued at $3,750,000. Finally, Prudential Financial Inc. increased its stake in shares of Steris Plc by 470.7% in the 1st quarter. Prudential Financial Inc. now owns 344,755 shares of the medical equipment provider’s stock valued at $23,947,000 after acquiring an additional 284,350 shares in the last quarter. Hedge funds and other institutional investors own 94.67% of the company’s stock.
Several research firms have recently weighed in on STE. Wellington Shields lowered shares of Steris Plc from a “gradually accumulate” rating to a “hold” rating in a research note on Monday, June 5th. BidaskClub lowered shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Raymond James Financial, Inc. lifted their price objective on shares of Steris Plc from $90.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, August 9th. Finally, Zacks Investment Research upgraded shares of Steris Plc from a “hold” rating to a “buy” rating and set a $92.00 price objective for the company in a research note on Tuesday, July 11th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Steris Plc has an average rating of “Buy” and an average target price of $86.75.
In other news, insider Kathleen Bardwell sold 3,795 shares of the firm’s stock in a transaction on Friday, June 16th. The stock was sold at an average price of $82.00, for a total transaction of $311,190.00. Following the completion of the transaction, the insider now directly owns 20,605 shares in the company, valued at $1,689,610. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Mohsen Sohi sold 2,744 shares of the firm’s stock in a transaction on Wednesday, August 9th. The shares were sold at an average price of $85.98, for a total value of $235,929.12. Following the transaction, the director now owns 21,816 shares of the company’s stock, valued at $1,875,739.68. The disclosure for this sale can be found here. Insiders have sold 23,809 shares of company stock valued at $2,010,258 over the last 90 days. Corporate insiders own 2.55% of the company’s stock.
Shares of Steris Plc (STE) opened at 87.48 on Tuesday. The stock has a 50 day moving average of $84.80 and a 200 day moving average of $77.51. Steris Plc has a 1-year low of $63.80 and a 1-year high of $88.11. The company has a market cap of $7.46 billion, a price-to-earnings ratio of 62.58 and a beta of 1.29.
Steris Plc (NYSE:STE) last posted its quarterly earnings data on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. The business had revenue of $608 million during the quarter, compared to the consensus estimate of $597.66 million. Steris Plc had a return on equity of 11.39% and a net margin of 4.63%. The firm’s quarterly revenue was down 4.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.79 earnings per share. Analysts predict that Steris Plc will post $4.06 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, September 28th. Stockholders of record on Tuesday, August 29th will be issued a dividend of $0.31 per share. The ex-dividend date is Friday, August 25th. This is an increase from Steris Plc’s previous quarterly dividend of $0.28. This represents a $1.24 annualized dividend and a dividend yield of 1.42%. Steris Plc’s dividend payout ratio (DPR) is presently 88.57%.
WARNING: “SG Americas Securities LLC Has $485,000 Holdings in Steris Plc (STE)” was originally published by Markets Daily and is the property of of Markets Daily. If you are reading this story on another domain, it was copied illegally and republished in violation of US & international trademark & copyright laws. The legal version of this story can be read at https://www.themarketsdaily.com/2017/09/12/sg-americas-securities-llc-has-485000-holdings-in-steris-plc-ste.html.
Steris Plc Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris Plc (NYSE:STE).
Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with MarketBeat.com's FREE daily email newsletter.